source
- Why Biopharma Executives Should Hire an ‘Implementer’ to Turn Ideas into ActionLeadership Lab is a new column aimed at biopharma leaders facing real‑world pressures. In the opening piece, Michael Pietrack of Kaye/Bassman International argues that the most valuable hire for an…
- Regeneron halts Phase 1/2 uveitis antibody trial after safety concernsRegeneron announced termination of a Phase 1/2 study of its investigational anti-inflammatory antibody REGN7041, which was being evaluated for non-infectious uveitis. The company said the decision…